Throughout the 52 week trial, none of the volunteers experienced any adverse reactions, and they all saw a boost in antibodies. This leaves scientists encouraged that Phase 2 will also see great success.
Since it emerged, HIV/AIDS has killed over 35 million people, and 34 million are currently living with it.
More info: http://bit.ly/15yFFIn
No comments:
Post a Comment